daunorubicin has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broglie, L; Dorrello, NV; Hijiya, N; Kaur, D; Pavisic, J; Phillips, L | 1 |
| Cobos, E; Keung, YK; Morgan, D | 1 |
2 other study(ies) available for daunorubicin and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
Topics: Adolescent; Allopurinol; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Daunorubicin; Fluid Therapy; Humans; Male; Methylprednisolone; Nitriles; Pandemics; Pneumonia, Viral; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Vincristine | 2020 |
Cocaine-contaminated allogeneic bone marrow transplantation.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bone Marrow Transplantation; Cocaine-Related Disorders; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Graft Survival; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Marijuana Abuse; Middle Aged; Recurrence; Salvage Therapy; Thrombocythemia, Essential; Tissue and Organ Procurement; Tissue Donors; Transplantation, Homologous | 2001 |